Ado-trastuzumab emtansine Intravenous and Signifor (Pasireotide Injection)
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Signifor (Pasireotide Injection) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Signifor, Signifor Injection
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Signifor Injection
- Ado-trastuzumab emtansine Intravenous-Signifor LAR
- Ado-trastuzumab emtansine Intravenous-Signifor LAR Injection
- Ado-trastuzumab emtansine Intravenous-Siklos
- Ado-trastuzumab emtansine Intravenous-Siladryl Allergy
- Ado-trastuzumab emtansine Intravenous-Silalite Pak
- Signifor (Pasireotide Injection)-Adox Pak 2/100
- Signifor (Pasireotide Injection)-Adoxa
- Signifor (Pasireotide Injection)-Adoxa CK
- Signifor (Pasireotide Injection)-Adoxa Pak
- Signifor (Pasireotide Injection)-Adoxa Pak 1/100
- Signifor (Pasireotide Injection)-Adoxa Pak 1/150